PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Khamashta, Munther
TI  - Sifalimumab Slows Disease Activity in SLE
DP  - 2014  01
TA  - MD Conference Express
PG  - 7--8
VI  - 14
IP  - 51
4099  - http://mdc.sagepub.com/content/14/51/7.short
4100  - http://mdc.sagepub.com/content/14/51/7.full
AB  - An investigational anti-interferon-a monoclonal antibody, sifalimumab, reduced global disease activity in patients with systemic lupus erythematosus (SLE). This article presents results from a phase 2b study of sifalimumab in patients with moderate to severe SLE.